SAT Hospital in Keralam rejects charges of ‘clinical trial drugs’ given to SMA-afflicted children
SAT Hospital in Kerala refuted claims it gave experimental drugs to children with spinal muscular atrophy. The hospital’s superintendent explained that a technical committee of specialists opted to supply a lower‑cost generic version of the approved SMA medication, replacing the imported brand that can cost several lakh rupees per vial. The imported product is priced at around five lakh rupees per vial, prompting the switch.